MRHL.TA - Merchavia Holdings and Investments Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
26.60
+0.10 (+0.38%)
At close: 2:24PM IDT
Stock chart is not supported by your current browser
Previous Close26.50
Open26.50
Bid26.50 x 5000
Ask28.00 x 3238300
Day's Range26.50 - 28.00
52 Week Range25.70 - 78.00
Volume5,462
Avg. Volume98,875
Market Cap16.64M
Beta (3Y Monthly)0.37
PE Ratio (TTM)1,266.67
EPS (TTM)0.02
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Merchavia Expands Its Investments in Diagnostics: The Company to Invest NIS 1 Million in EFA - Engineering for All Ltd.

    EFA develops a revolutionary accurate portable diagnostic system for real-time testing and disease mapping in which the first application to the market will be conducting blood counts (CBC) and other examinations, using blood sample. Meeting the global need to reduce excessive use of antibiotics and to bring access to critical tests to everyone everywhere.

  • PR Newswire

    Merchavia Announces First Investment Agreement in the Medical Cannabis Sector

    RAMAT GAN, Israel, March 19, 2019 /PRNewswire/ -- Merchavia Holdings and Investments (MRHL.TA), an Israeli investment company specializing in early stage life sciences companies, announces that it has signed an investment agreement for allocating shares of Veoli, which develops technology for consuming cannabis in precise dosages without requiring heating or burning.

  • PR Newswire

    Merchavia Holdings Completes Successful Offering in TASE

    Merchavia Holdings and Investments (MRHL.TA), an Israeli investment company specializing in early stage life sciences companies, announces completion of a successful offering in shares and options. As part of the offering, the company offered 46,000 units including option warrants, 100 shares, 50 series 2 option warrants, at an exercise price of NIS 0.48, that can be exercised by 17.1.2019, and 50 series 3 option warrants of NIS 0.85, that can be exercised by 28.11.2019.

  • PR Newswire

    Merchavia's Portfolio Company 'Juventas' Announces Strategic Commercialization Agreement

    The company signed an exclusive worldwide options and licensing agreement with Japanese giant 'Astellas Pharma' for the development and acquisition of Juventas's technological applications - contingent ...

  • PR Newswire

    Merchavia Signs MoU for First Investment in the Medical Cannabis Sector

    RAMAT GAN, Israel, Nov. 26, 2018 /PRNewswire/ -- Merchavia Holdings and Investments (MRHL.TA), an Israeli investment company specializing in early-stage life science sector companies, announces that it has signed a non-binding Memorandum of Understanding (MoU) in an Israeli company developing a medical device that will allow the measured and precise consumption of medical cannabis, according to a pre-defined dosage and without the need of heating. According to the MoU, the company will invest a total of $400,000 in exchange for shares representing about 20% on a fully diluted basis. As part of this strategy, and following the company's announcement one month ago, about its intention to begin investing in companies in the Cannabis field, when the deal becomes a binding agreement, Merchavia will invest for the first time in the aforementioned company.